Atlas Venture Life Science Advisors, LLC Day One Biopharmaceuticals, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $455 Million
- Q2 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 6,430,257 shares of DAWN stock, worth $45.3 Million. This represents 9.19% of its overall portfolio holdings.
Number of Shares
6,430,257
Previous 6,430,257
-0.0%
Holding current value
$45.3 Million
Previous $51 Million
18.03%
% of portfolio
9.19%
Previous 14.93%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
184Shares Held
70.7MCall Options Held
122KPut Options Held
85.5K-
Vanguard Group Inc Valley Forge, PA6.18MShares$43.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$31.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$28.8 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$26.2 Million0.56% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.72MShares$26.2 Million0.03% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $517M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...